#$GPCR
Simran Singh et al. report that Gq signaling links macrophage lipid sensing to impaired insulin secretion and identify an endocannabinoid-sensitive GPCR, GPR18, upstream of Gq activation in islet macrophages 🧪: doi.org/10.1172/JCI2...
@iamashish008.bsky.social
November 16, 2026 at 9:02 PM
GPCR-Mediated Regulation of Cytochrome P450 Drives Sulfoxaflor Resistance in Aphis gossypii Glover
#Drosophila
GPCR-Mediated Regulation of Cytochrome P450 Drives Sulfoxaflor Resistance in Aphis gossypii Glover #Drosophila
PubMed link
pubmed.ncbi.nlm.nih.gov
November 16, 2026 at 11:23 AM
It reached an F1 score of 0.875 distinguishing GPCR from non-GPCR ligands, and its LightGBM module surfaced target-selective scaffolds including fluorinated fragments in CCR6 inhibitors and nitrogen-rich heterocycles in CXCR3 inhibitors.
November 16, 2026 at 11:03 AM
Structural Determinants of Biologic Recognition Across GPCR Classes pubmed.ncbi.nlm.nih.gov/43027316/ #cryoem
November 15, 2026 at 9:19 PM
Scientists propose rebalancing the GPCR receptor family, which 40 percent of drugs already target, to delay several diseases of aging at the same time.
Scientists have a bold new plan to slow down human aging by changing how our cells talk to each other
www.earth.com
November 18, 2026 at 1:59 PM
The authors included RRIDs in their in Biomedicines paper! Thanks for making your methods matter! #RRID #ReproducibleResearch #accelerateopenscience
Dissecting GPCR Contributions to Gαo-Dependent Motor Dysfunction in GNAO1-Related Disorders Using Caenorhabditis elegans
Read the full paper: Dissecting GPCR Contributions to Gαo-Dependent Motor Dysfunction in GNAO1-Related Disorders Using Caenorhabditis elegans
doi.org
November 18, 2026 at 8:00 AM
what should i read to learn more about the GPCR? i read a beast slinks towards beijing which was a fine magical realist chinese diaspora intergenerational trauma story until the halfway mark when it kept insisting the GPCR was WORSE than the japanese occupation lmao.
November 16, 2026 at 5:13 AM
#UCDavisIPN postdoctoral scholar Cassandra Hatzipantelis published a Viewpoint in @acs.org - Neuroscience on evaluating drugs that activate helpful cell signals while avoiding side effects, and why current methods may miss what matters most to patients. #Neuroscience #Pharmacology Read the pub:
The Potency Problem in GPCR Biased Agonism
Abstract. Biased agonism promised a new generation of GPCR therapeutics capable of selectively engaging beneficial signaling pathways while avoiding those
pubs.acs.org
November 18, 2026 at 6:19 PM
Examining G protein–coupled receptor signaling in uveal melanoma cell lines, researchers have discovered a way to make these cells more sensitive to compounds that inhibit cancer-linked signaling pathways. #ScienceSignaling https://scim.ag/4sPXe2e
Gq-coupled GPCRs mediate the oncogenic activity of Gαq-Q209L/P mutants in uveal melanoma cells
Blocking a Gq-coupled GPCR sensitizes uveal melanoma cells to an inhibitor of constitutively active G proteins.
scim.ag
November 13, 2026 at 4:00 PM
Scientists have a bold new plan to slow down human aging by changing how our cells talk to each other: www.earth.com/lifestyle/sc...
Scientists have a bold new plan to slow down human aging by changing how our cells talk to each other
Scientists propose rebalancing the GPCR receptor family, which 40 percent of drugs already target, to delay several diseases of aging at the same time.
www.earth.com
November 18, 2026 at 2:14 AM
Frontiers in Science Deep Dive webinar series | Rebalancing the body’s cellular communication system could slow aging | EurekAlert! www.eurekalert.org/news-release...
Frontiers in Science Deep Dive webinar series | Rebalancing the body’s cellular communication system could slow aging
Discover how shifting the balance between pro-aging and pro-longevity G protein-coupled receptor (GPCR) signaling networks could open new ways to treat aging and age-related diseases.
www.eurekalert.org
November 17, 2026 at 2:38 AM
Nuclera and @cambiochem.bsky.social have demonstrated rapid structural analysis of a challenging drug target by achieving a 3.38A structure of a GPCR, with just 4 days from gene assembly to sample preparation for cryo-EM. bit.ly/4kE6e8X
November 17, 2026 at 9:43 AM
Cell-line sensitization is a mechanism signal, not yet a treatment result. The next step is to test whether GPCR blockade widens the therapeutic window across genetically diverse models while separating on-target pathway suppression from general toxicity.
November 13, 2026 at 6:02 PM
Scientists propose rebalancing the GPCR receptor family, which 40 percent of drugs already target, to delay several diseases of aging at the same time.
Scientists have a bold new plan to slow down human aging by changing how our cells talk to each other
www.earth.com
November 17, 2026 at 11:01 AM
Read ‘GPCR-MAPS: high-resolution functional and allosteric mapping of G-protein-coupled receptor activation functions and bias’ from @sangerinstitute.bsky.social & @crg.eu in @natsmb.nature.com, here ⤵️
www.nature.com/articles/s41...
GPCR-MAPS: high-resolution functional and allosteric mapping of G-protein-coupled receptor activation functions and bias - Nature Structural & Molecular Biology
Mighell and Lehner present GPCR-MAPS, which enables scalable functional mapping of G-protein-coupled receptors. They obtained measurements across multiple phenotypes of the β2 adrenergic receptor to r...
www.nature.com
November 12, 2026 at 4:46 PM
www.wiseguyreports.com
November 11, 2026 at 10:25 AM
there's a Woke Nuanced trope in historiography of socialism that's like "people have assumed that korenizatsiya/Hundred Flowers/United Front work in Tibet/GPCR was done for cynically utilitarian motives by people who knew they would drop it as soon as it didn't benefit them.
November 11, 2026 at 12:40 AM
Biotech catalysts today (Tue Nov 17)
$ACAD data readout
$CRBP presents at ObesityWeek (CRB-913)
$CRDF conference presentation (Onvansertib)
+2 more on the site
Dates from the companies' SEC filings
#Biotech #Stocks

Visit for more info: www.elixstocks.com
Educational only. Not investment advice.
Biotech catalysts today — ElixStocks
$ACAD data readout; $CRBP presents at ObesityWeek (CRB-913); $CRDF conference presentation (Onvansertib); $GPCR presents at ObesityWeek
elixstocks.com
November 17, 2026 at 12:15 PM
🧬 ObesityWeek 2026 is on — Nov 14–17, National Harbor. #$LLY leads: EloraTZP 23.3%, retatrutide sleep-apnea data. #$NVO answers Sunday with lower-dose CagriSema, Monday with STEP-YOUNG. On the board: #$GPCR, #$VKTX, #$RHHBY, #$ZEAL, #$BHVN, #$WVE. #$AMGN's MariTide isn't presenting. Watch the poster
November 15, 2026 at 12:39 AM
$GPCR Structure Therapeutics: $1.2B cash, Phase 3 trials enrolling (Q3 2026)
Hub: https://www.merlintrader.com/structure-therapeutics-gpcr-stock-hub/?utm_source=bluesky&utm_medium=social&utm_campaign=flyer-q3-2026&utm_content=gpcr

Not investment advice.
November 10, 2026 at 9:40 PM
Functional diversity of GPCR-Gustducin complexes controls signaling output and suppresses alternative pathways
Given the divergent signaling cascades promoted upon Ggust dissociation into Gαgust and Gβγ, we aimed to develop a signaling-pathway independent readout of Ggust activation. In line with the placement of energy partners in a TRUPATH Ggust heterotrimer dissociation sensor16, we fused NanoLuciferase17 (Nluc), flanked by flexible linkers, to Asp116 in Gαgust. Next, we combined the sequence of Gαgust-Nluc with the wild-type Gβ3 gene and N-terminally labeled Gγ9 on a plasmid backbone comprising a T2A self-cleavage site (between Gβ3 and cpVenus-Gγ9) and an internal ribosome entry site (IRES; upstream of Gαgust-Nluc), because this Gβγ dimer fused with the optimized energy acceptor cpVenus18,19 proved to be a sensitive module to detect the dissociation of other G protein heterotrimers20,21. This plasmid design enabled the simultaneous co-transfection and expression of all three G protein subunits (Fig. 1A, Supplementary Fig. 1A). To facilitate the future combination of this sensor, which we refer to as Ggust-CASE, with other optical biosensors, we created a version of G-CASE with a dimmed BRET acceptor (“dark Ggust-CASE”) by mutating Tyr218 in cpVenus to Trp22. The quenched emission of cpVenus was confirmed in the luminescence emission spectra of transfected cells (Fig. 1B). Starting from dark Ggust-CASE, we also generated a Ggust-CASE...
www.nature.com
November 14, 2026 at 8:53 PM
The authors included RRIDs in their in Nature paper! We value the author's support of reproducibility. #accelerateopenscience #OpenScience #OpenResearch
TM184C is a GPCR-like regulator of intercellular exchange and autophagy - Nature
TM184C—an ancient G-protein-coupled receptor-like superdark protein involved in regulation of autophagy, intercellular connectivity and material exchange—underscores the promise of exploring the understudied human proteome and beyond.
doi.org
November 15, 2026 at 8:02 AM